The Uromigos

401 Episodes

1. Episode 123: Maha Hussain - The Uromigos Legends in GU Cancer series

   Published: 8/20/2021
2. Episode 122: Nick Vogelzang - The Uromigos Legends in GU Cancer series

   Published: 8/16/2021
3. Episode 121: Conflicts of Interest with the podcasts

   Published: 8/4/2021
4. Episode 119: EAU - Surgery in urothelial cancer

   Published: 7/23/2021
5. Episode 118: Prostate cancer highlights at EAU

   Published: 7/20/2021
6. Episode 117: PD1/VEGF adverse event management in renal cancer

   Published: 7/20/2021
7. Episode 116: Renal cancer surgery controversies at EAU

   Published: 7/14/2021
8. Episode 112: Genomic classifier of high risk African American men with prostate cancer identifying a high-risk population

   Published: 7/5/2021
9. Episode 115: Triplet therapy for 1st line metastatic prostate cancer

   Published: 7/1/2021
10. Episode 114: Radionucleotides in prostate cancer

    Published: 6/18/2021
11. Episode 113: ASCO 2021 Enazlutamide +/- Radium-223

    Published: 6/18/2021
12. Episode 111: The randomised phase 3 CANTATA in metastatic renal cancer

    Published: 6/8/2021
13. Episode 110: PEACE1 - Triplet therapy in prostate cancer

    Published: 6/8/2021
14. Episode 109: Adjuvant pembrolizumab in renal cancer

    Published: 6/7/2021
15. Episode 108: Peter O'Donnell gives five year follow-up data on front line pembrolizumab in urothelial cancer

    Published: 6/7/2021
16. Episode 107: ASCO 2021: Neoadjuvant chemo/nivolumab as bladder sparing

    Published: 6/7/2021
17. Episode 106: Summary of the three bladder sparing neoadjuvant trials at ASCO 2021

    Published: 6/7/2021
18. Episode 105: A Phase 2 study of novel immune combinations (ICOS) in bladder cancer

    Published: 6/7/2021
19. Episode 104: Plenary Session 177lu-PSMA-617 in Prostate Cancer

    Published: 6/6/2021
20. Episode 103: Targeting the microbiome to increase the activity of immune therapy in renal cancer

    Published: 6/6/2021